The relationship between neutrophil to lymphocyte ratio, platelet to lymphocyte ratio and thrombolysis in myocardial infarction risk score in patients with ST elevation acute myocardial infarction before primary coronary intervention
Yazarlar (15)
Halit Acet Dicle Üniversitesi, Türkiye
Faruk Ertaş Dicle Üniversitesi, Türkiye
Mehmet Zihni Bilik Dicle Üniversitesi, Türkiye
Mehmet Ata Akıl Dicle Üniversitesi, Türkiye
Ferhat Özyurtlu İzmir Üniversitesi, Türkiye
Mesut Aydın Dicle Üniversitesi, Türkiye
Mustafa Oylumlu Dicle Üniversitesi, Türkiye
Nihat Polat Dicle Üniversitesi, Türkiye
Murat Yüksel Dicle Üniversitesi, Türkiye
Prof. Dr. Abdulkadir YILDIZ Dicle Üniversitesi, Türkiye
Hasan Kaya Dicle Üniversitesi, Türkiye
Abdurrahman Akyuz Dicle Üniversitesi, Türkiye
Hilal Ayçiçek Dicle Üniversitesi, Türkiye
Mehmet Özbek Dicle Üniversitesi, Türkiye
Nizamettin Toprak Dicle Üniversitesi, Türkiye
Makale Türü Açık Erişim Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale)
Dergi Adı Postepy W Kardiologii Interwencyjnej
Dergi ISSN 1734-9338 Wos Dergi Scopus Dergi
Dergi Tarandığı Indeksler SCI-Expanded
Makale Dili İngilizce Basım Tarihi 01-2015
Cilt / Sayı / Sayfa 11 / 2 / 126–135 DOI 10.5114/pwki.2015.52286
Makale Linki http://www.termedia.pl/doi/10.5114/pwki.2015.52286
Özet
Introduction: The thrombolysis in myocardial infarction (TIMI) risk score is calculated as the sum of independent predictors of mortality and ischemic events in ST elevation acute myocardial infarction (STEMI). Several studies show that the neutrophil to lymphocyte ratio (NLR) is a prognostic inflammatory marker. In preliminary studies, platelet to lymphocyte ratio (PLR) has been proposed as a pro-thrombotic marker. The relationship between NLR, PLR and TIMI risk score for STEMI has never been studied. Aim: To evaluate the association between TIMI-STEMI risk score and NLR, PLR and other biochemical indices in STEMI. Material and methods: In this retrospective study, we evaluated 390 patients who presented with STEMI within 12 h of symptom onset. Patients were grouped according to low and high TIMI risk scores. Results: We enrolled 390 patients (mean age 61.9 ±13.6 years; 73% were men). The NLR, platelet distribution width (PDW) and uric acid level (UA) were significantly associated with a high TIMI-STEMI risk score (p = 0.016, p = 0.008, p = 0.030, respectively), but PLR was not associated with a high TIMI-STEMI risk score. Left ventricular ejection fraction was an independent predictor of TIMI-STEMI risk score. A cut-off point of TIMI-STEMI score of > 4 predicted in-hospital mortality (sensitivity 75%, specificity 70%, p < 0.001). We found that NLR, PDW, and UA level were associated with TIMI-STEMI risk score. Conclusions: Neutrophil to lymphocyte ratio, PDW and UA level are convenient, inexpensive and reproducible biomarkers for STEMI prognosis before primary angioplasty when these indicators are combined with the TIMI-STEMI risk score. We believe that these significant findings can guide further clinical practice.
Anahtar Kelimeler
Hematologic indices | Neutrophil to lymphocyte ratio | Platelet to lymphocyte ratio | Stemi | Timi risk score